About Davis Select U.S. Equity ETF (NASDAQ:DUSA)
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company's marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.
Industry, Sector and Symbol:
- Industry: N/A
- Sub-Industry: N/A
- Sector: Healthcare
- Symbol: NASDAQ:DUSA
- CUSIP: N/A
- Web: N/A
- Outstanding Shares: 3,500,000
Frequently Asked Questions for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
What is Davis Select U.S. Equity ETF's stock symbol?
Davis Select U.S. Equity ETF trades on the NASDAQ under the ticker symbol "DUSA."
Who are some of Davis Select U.S. Equity ETF's key competitors?
Some companies that are related to Davis Select U.S. Equity ETF include Silence Therapeutics plc (SLN), Alliance HealthCare Services (AIQ), Knight Therapeutics (GUD), Bioventix PLC (BVXP), ImmuPharma PLC (IMM), Advaxis (ADXS), Conatus Pharmaceuticals (CNAT), Trivascular Technologies (TRIV), Complete Genomics (GNOM), AcelRx Pharmaceuticals (ACRX), Galmed Pharmaceuticals (GLMD), Cannabis Science (CBIS), Motif Bio plc (MTFB), Immunodiagnostic Systems Holdings PLC (IDH), Synthetic Biologics (SYN), Diurnal Group PLC (DNL), NovaBay Pharmaceuticals (NBY) and Ergomed PLC (ERGO).
Who owns Davis Select U.S. Equity ETF stock?
Davis Select U.S. Equity ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Davis Selected Advisers (59.71%), Citadel Advisors LLC (1.16%), D.A. Davidson & CO. (0.73%), Jane Street Group LLC (0.41%) and Private Advisor Group LLC (0.32%). View Institutional Ownership Trends for Davis Select U.S. Equity ETF.
Who bought Davis Select U.S. Equity ETF stock? Who is buying Davis Select U.S. Equity ETF stock?
How do I buy Davis Select U.S. Equity ETF stock?
Shares of Davis Select U.S. Equity ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Davis Select U.S. Equity ETF's stock price today?
One share of Davis Select U.S. Equity ETF stock can currently be purchased for approximately $22.35.
How big of a company is Davis Select U.S. Equity ETF?
Davis Select U.S. Equity ETF has a market capitalization of $71.47 million.
MarketBeat Community Rating for Davis Select U.S. Equity ETF (NASDAQ DUSA)MarketBeat's community ratings are surveys of what our community members think about Davis Select U.S. Equity ETF and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Davis Select U.S. Equity ETF (NASDAQ:DUSA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
Analysts' Ratings History for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
Earnings History by Quarter for Davis Select U.S. Equity ETF (NASDAQ DUSA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Davis Select U.S. Equity ETF (NASDAQ:DUSA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Davis Select U.S. Equity ETF (NASDAQ DUSA)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Davis Select U.S. Equity ETF (NASDAQ DUSA)
Davis Select U.S. Equity ETF (NASDAQ DUSA) Chart for Wednesday, November, 22, 2017